These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 1161970)
1. Platelet monoamine oxidase activity during the course of a schizophreniform psychosis. Cookson IB; Owen F; Ridges AP Psychol Med; 1975 Aug; 5(3):314-6. PubMed ID: 1161970 [TBL] [Abstract][Full Text] [Related]
2. Platelet monoamine oxidase activity in subgroups of schizophrenic disorders. Schildkraut JJ; Orsulak PJ; Schatzberg AF; Herzog JM Schizophr Bull; 1980; 6(2):220-5. PubMed ID: 7375853 [TBL] [Abstract][Full Text] [Related]
3. Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders. Orsulak PJ; Schildkraut JJ; Schatzberg AF; Herzog JM Biol Psychiatry; 1978 Dec; 13(6):637-47. PubMed ID: 737252 [TBL] [Abstract][Full Text] [Related]
4. Delusional misidentification and platelet monoamine oxidase. Barton JL; Chaparala S; Barton ES; Jackson IV; Davis LG Biol Psychiatry; 1980 Apr; 15(2):275-82. PubMed ID: 7417616 [TBL] [Abstract][Full Text] [Related]
5. Platelet monoamine oxidase activity in schizophrenia. Relationship to disease, treatment, institutionalization and outcome. Mann J; Thomas KM Br J Psychiatry; 1979 Apr; 134():366-71. PubMed ID: 36192 [TBL] [Abstract][Full Text] [Related]
6. Platelet monoamine-oxidase activity in schizophrenia. Relation to genetic load of the illness and treatment with antipsychotic drugs. Kemali D; Maj M; Ariano MG; Salvati A Encephale; 1985; 11(1):31-4. PubMed ID: 2859981 [TBL] [Abstract][Full Text] [Related]
7. Platelet monoamine oxidase activity and schizophrenia. Meltzer HY; Arora RC; Babar R; Jackman H; Nasr S; Pscheidt G; Smith M; Strahilevitz M Arch Gen Psychiatry; 1980 Mar; 37(3):357. PubMed ID: 7362423 [No Abstract] [Full Text] [Related]
8. Platelet monamine oxidase in schizophrenia. An investigation in drug-free chronic hospitalized patients. Owen F; Bourne R; Crow TJ; Johnstone EC; Bailey AR; Hershon HI Arch Gen Psychiatry; 1976 Nov; 33(11):1370-3. PubMed ID: 791182 [TBL] [Abstract][Full Text] [Related]
10. Neuroleptic-induced decrease in platelet MAO activity of schizophrenic patients. Chojnacki M; Kralik P; Allen RH; Ho BT; Schoolar JC; Smith RC Am J Psychiatry; 1981 Jun; 138(6):838-40. PubMed ID: 6113772 [No Abstract] [Full Text] [Related]
11. Effects of neuroleptics on platelet monoamine oxidase activity. Ho BT; Smith RC; Kralik P; Allen R; Schoolar J; Khan M; DeJohn C Biol Psychiatry; 1982 Aug; 17(8):885-95. PubMed ID: 6126230 [TBL] [Abstract][Full Text] [Related]
12. Monoamine oxidase (MAO) of platelets, plasma, lymphocytes and granulocytes in schizophrenia. Bond PA; Cundall RL; Falloon IR Br J Psychiatry; 1979 Apr; 134():360-5. PubMed ID: 444786 [TBL] [Abstract][Full Text] [Related]
14. Reduced platelet monoamine oxidase activity in a subgroup of schizophrenic patients. Schildkraut JJ; Herzog JM; Orsulak PJ; Edelman SE; Shein HM; Frazier SH Am J Psychiatry; 1976 Apr; 133(4):438-40. PubMed ID: 1267046 [TBL] [Abstract][Full Text] [Related]
15. Neuroleptic drug effect on platelet monoamine oxidase and plasma amine oxidase in schizophrenia. Baron M; Gruen R; Levitt M; Kane J Psychiatry Res; 1982 Oct; 7(2):179-87. PubMed ID: 6128754 [TBL] [Abstract][Full Text] [Related]